Gunnar Juliusson
81 – 90 of 159
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Incidence and prognostic significance of karyotypic subgroups in older patients with acute myeloid leukemia: the Swedish population-based experience.
- Contribution to journal › Article
-
Mark
On the way towards a 'CLL prognostic index': focus on TP53, BIRC3, SF3B1, NOTCH1 and MYD88 in a population-based cohort
- Contribution to journal › Letter
-
Mark
Feasibility of targeted next-generation sequencing of the TP53 and ATM genes in chronic lymphocytic leukemia
- Contribution to journal › Letter
-
Mark
A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia.
- Contribution to journal › Article
-
Mark
Bortezomib, melphalan, prednisone (VMP) versus melphalan, prednisone, thalidomide (MPT) in elderly newly diagnosed multiple myeloma patients: A retrospective case-matched study
- Contribution to journal › Article
- 2013
-
Mark
NOTCH1 mutations influence survival in chronic lymphocytic leukemia patients
- Contribution to journal › Article
-
Mark
Safety of thalidomide in newly diagnosed elderly myeloma patients: a meta-analysis of data from individual patients in six randomized trials
- Contribution to journal › Article
-
Mark
450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments
- Contribution to journal › Article
-
Mark
NOTCH1 and SF3B1 mutations can be added to the hierarchical prognostic classification in chronic lymphocytic leukemia
- Contribution to journal › Letter
-
Mark
rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
- Contribution to journal › Article
